Kidney Dialysis & Chronic Kidney Disease Treatment
in China — Multidisciplinary Assessment Guidance
Backed by leading public Class-A tertiary nephrology centers and national regional medical centers in China, MedTravel China provides rigorous, transparent treatment-feasibility assessment for international patients with chronic kidney disease (CKD stages 1–5), refractory nephrotic syndrome, complex hemodialysis vascular access conditions and end-stage kidney failure — including multidisciplinary team (MDT) consultation coordination and fully compliant cross-border care.
Cross-border kidney care involves long-term biochemical monitoring, second-opinion pathology review and dialysis scheduling across borders. MedTravel China follows a strict medical review process so that patients never travel to China without a valid indication.
Important legal notice: China strictly enforces its Regulations on Human Organ Transplantation, and any trade in human organs is a serious criminal offense. This platform upholds international medical ethics: we never broker or solicit organs, and we make no promise regarding donor sources or expedited transplant scheduling.
China's National Kidney Centers: Clinical Strengths & Facilities
China's top nephrology departments typically operate multi-million-yuan in-house pathology laboratories, high-standard laminar-flow dialysis units and hybrid minimally invasive operating suites, safeguarding precision across the entire treatment pathway.
Precision Kidney Biopsy & Ultrastructural Pathology Diagnosis
Full light microscopy, direct immunofluorescence (IF) and transmission electron microscopy (TEM) ultrastructural examination — delivering molecular-pathology-guided precision for rare primary and secondary glomerular diseases and podocyte disorders.
High-Flux Hemodialysis & Purification Center
Class 100/1,000 laminar-flow purification halls with double-stage reverse-osmosis ultrapure water systems, on-line hemodiafiltration (HDF), hemoperfusion (HP) and continuous renal replacement therapy (CRRT).
Hybrid Ultrasound & DSA Vascular Access Operating Suite
Combining high-frequency contrast-enhanced ultrasound with digital subtraction angiography (DSA) for ultrasound-guided percutaneous transluminal angioplasty (PTA) of fistulas, catheter-directed thrombolysis and thrombectomy, and construction of complex arteriovenous grafts (AVG).
Suitable Patients: When Should You Submit a Kidney Case Assessment?
Clear indications are the foundation of successful cross-border care. China's renal multidisciplinary teams conduct cross-border assessments mainly for the four groups of difficult or critical-stage patients below, spanning CKD, dialysis and kidney transplant concerns.
Refractory Nephrotic Syndrome & Secondary Kidney Injury
Patients with membranous nephropathy (MN), lupus nephritis (LN), IgA nephropathy, focal segmental glomerulosclerosis (FSGS) or ANCA-associated vasculitis who are resistant or frequently relapsing on standard full-dose steroids plus cytotoxic immunosuppressants, calcineurin inhibitors or other immunosuppressants — seeking next-generation monoclonal biologics (such as anti-CD20 agents and complement inhibitors) and integrated TCM–Western combination regimens.
Integrated Kidney-Sparing Care for Chronic Kidney Disease (CKD Stages 3–4)
Patients with steadily rising serum creatinine (150–450 μmol/L), heavy proteinuria with hypertension or metabolic acidosis who want a national flagship team's individualized plan — low-protein diet with α-ketoacid nutritional support, novel renoprotective agents such as SGLT2 inhibitors and finerenone, plus herbal rectal-dialysis detoxification — to protect residual nephrons and delay dialysis for as long as possible.
End-Stage Dialysis Vascular Access Failure, Stenosis & Reconstruction
Maintenance hemodialysis patients with severe AV fistula anastomotic stenosis, insufficient dialysis flow, acute thrombosis, pseudoaneurysm or central venous stenosis with "swollen arm syndrome," when local capabilities cannot restore the access — requiring high-level hybrid balloon angioplasty (PTA) or transposition and arteriovenous graft (AVG) bypass surgery to rebuild the lifeline.
End-Stage Renal Disease (ESRD) & Cross-Border Kidney Transplant Consultation
Patients already on maintenance dialysis seeking assessment at Chinese public hospitals for dialysis complications (secondary hyperparathyroid bone disease, severe cardiovascular calcification), as well as evaluation of clinical indications for kidney transplantation within China's statutory framework and pre-notarization legal review for cross-border living related kidney donation (restricted by law to direct-line or collateral relatives within three generations).
Why Patients Worldwide Choose Top Public Renal Centers in China
Immense Clinical Volumes & Detailed Pathology
National kidney centers rank first worldwide in annual outpatient and biopsy volumes, with exceptionally deep experience in differential diagnosis and pathological classification of difficult entities such as atypical membranous nephropathy and IgG4-related kidney disease.
Mature Minimally Invasive Vascular Access Care
Under ultrasound and DSA guidance, high-pressure and drug-coated balloons (DCB) treat refractory stenosis, with vascular access salvage success above 95% and a sharp reduction in open reconstructions and catheter-related suffering.
National Flagship Integrated TCM–Western Kidney Care
Western medicines control intraglomerular pressure and inflammation, while classic kidney-preserving formulas from renowned TCM physicians and herbal colon-lavage dialysis help drain uremic toxins — together easing fatigue and edema and delaying toxin accumulation.
Transparent Costs & Global Affordability
Public Class-A tertiary hospitals charge strictly government-approved rates; combined costs for high-flux dialysis, vascular access interventions and advanced monoclonal antibody therapy run only 1/4 to 1/6 of private specialist hospitals in the US, Europe or the Middle East.
Recommended Kidney Records & Lab Test Checklist
To let top Chinese experts make an accurate, evidence-based assessment, please gather recent serial test reports in original form (scans or high-resolution photos).
Serial serum creatinine (Cr), blood urea nitrogen (BUN), uric acid (UA), estimated glomerular filtration rate (eGFR), potassium, calcium, phosphate and CO2 combining power (CO2-CP) from the past 1–3 months.
Urine sediment analysis, phase-contrast microscopy of red-cell morphology (to distinguish glomerular hematuria), 24-hour urine protein quantification and the urine albumin-to-creatinine ratio (ACR).
If you have had a kidney biopsy, provide the light-microscopy diagnostic report with clear images, direct immunofluorescence grades (IgA, IgG, C3, C1q) and the electron-microscopy ultrastructural description; digital whole-slide scans are welcome if available.
Documenting kidney length, cortical thickness and echogenicity, plus renal-artery color Doppler resistive indices; provide DICOM source files if cysts, stones or masses are present.
Current hemodialysis or peritoneal dialysis prescription, target dry weight, anticoagulant type, and recent parathyroid hormone (iPTH) and ferritin levels; plus prior fistula surgical records and anastomosis color Doppler studies.
Medical Records Submission Portal
Supported: PDF, DICOM, ZIP, JPG (up to 500MB per file)You can upload scans directly through the form, or paste a cloud-storage link for large radiology studies (CT/MRI DICOM packages) in the field below. An international coordinator will securely retrieve and decode them in line with international medical data standards.
Drag your medical files here, or go straight to the official submission page
Go to the Encrypted Submission FormKey Nephrology Sub-Specialties & Collaborative Directions
Each disease pathology and clinical stage is matched precisely to the corresponding sub-specialty direction of China's national key clinical departments.
Glomerular Disease & Nephrotic Syndrome Center
Advanced immunomodulatory and podocyte-protective regimens for primary membranous nephropathy, IgA nephropathy (including novel targeted agents developed in China with independent intellectual property), focal segmental glomerulosclerosis (FSGS) and minimal change disease.
Secondary Kidney Disease & Rheumatology-Immunology Collaboration
Multidisciplinary assessment for diabetic kidney disease (DKD), lupus nephritis (LN), ANCA-associated vasculitis kidney injury and multiple-myeloma-related kidney damage, with precisely targeted control of these systemic, multi-organ conditions.
Blood Purification & Peritoneal Dialysis Center
Ultrapure hemodialysis (HD), hemodiafiltration (HDF) and automated peritoneal dialysis (APD) with standardized catheter placement and prescription adjustment, plus deep management of severe uremic cardiovascular complications and chronic kidney disease–mineral and bone disorder (CKD-MBD).
Vascular Access Intervention & Surgery Center
Complex arteriovenous fistula (AVF) creation, arteriovenous graft (AVG) implantation, percutaneous transluminal angioplasty (PTA), placement of cuffed tunneled central venous dialysis catheters, and revision of infected or occluded fistulas.
Integrated TCM–Western Kidney Rehabilitation Center
Based at national flagship hospitals for integrated TCM and Western medicine, using standardized herbal formulas taken orally, colorectal dialysis enemas, herbal acupoint application and steam therapy to ease tubulointerstitial fibrosis, improve symptoms and slow progression toward dialysis.
End-Stage Assessment & Kidney Transplant Consultation
Assessment of end-stage uremia tolerance across organ systems, guidance on high-resolution HLA matching review between donor and recipient, screening of indications for statutory related living-donor kidney transplantation, and step-by-step help with lawful notarization procedures.
Kidney Dialysis & Treatment Costs: Composition & Key Variables
Nephrology costs vary enormously with individual pathology stage and treatment modality. China's public system is highly transparent: you pay in-hospital, directly from the nationally published fee schedule.
Whether refractory heart failure, severe hyperkalemia, serious pulmonary infection or metabolic encephalopathy is present directly drives in-hospital infection management, monitoring level and duration of medication.
Outpatient integrated medical management vs. day-case minimally invasive vascular access PTA balloon angioplasty vs. continuous CRRT/high-flux dialysis bed fees.
Domestic volume-based procurement kidney-protective drugs offer outstanding value; new originator monoclonal antibodies (e.g., anti-CD20 monoclonal antibodies, complement inhibitors) are billed at China's official tender-listed hospital prices.
Kidney biopsy usually requires 24–48 hours of observation; access angioplasty typically 1–3 days; complex kidney failure with infection commonly means 1–2 weeks in hospital.
MedTravel China's Third-Party Service Commitment & Boundaries
We charge a transparent, fixed USD 300 medical record pre-review and coordination fee and act strictly as an objective third-party advisor — we never add any markup or hidden commission to hospital medical fees.
- check Bilingual standardized organization of overseas records & biopsy pathology
- check Pre-review by renal specialists at associate-chief-physician level or above in top public Class-A tertiary hospitals
- check An official treatment-indication assessment report and budget range for travel to China
- check All downstream treatment costs settled by you directly, in person, at hospital counters
Medical Ethics & Legal Red Lines in Organ Transplantation
Clinical Governance & Legal RedlinesThe People's Republic of China enforces one of the world's most rigorous legal and regulatory systems for human organ transplantation. International patients seeking end-stage kidney replacement therapy or transplant consultation in China must understand and unconditionally comply with the following legal cornerstones:
Chinese law severely punishes and absolutely prohibits any form of organ trading or commercialized transplantation. Organs voluntarily donated after death are allocated solely and automatically through the China Organ Transplant Response System (COTRS); no intermediary may interfere with allocation or scheduling.
For living-donor kidney transplant applications by international patients, donor and recipient must be spouses, direct-line relatives or collateral relatives within three generations. Notarized kinship certificates authenticated by both countries' authorities and consulates, plus an independent in-person review before the hospital ethics committee, are non-negotiable statutory requirements.
MedTravel China is a legitimate cross-border consultation organization. We categorically reject false promises, rush guarantees or any commercial organ brokerage. We provide only medical coordination with the nephrology, dialysis management and lawful transplant departments of accredited public Class-A tertiary hospitals.
Kidney Treatment in China: Top Questions Answered
Rigorous, science-based answers on the questions patients and families ask most: reversing rising creatinine, repairing dialysis access, transplant policy and integrated TCM–Western treatment.
Ready to Submit Your Kidney Records for an Expert Assessment at a Top Chinese Hospital?
Upload recent kidney function reports, urine test results and ultrasound or pathology originals. A dedicated international coordinator will standardize them within 48 hours and route them to a national key nephrology team for medical pre-review.
Review hotline: +86 13702335733 · Urgent kidney consultation email: vip@chinamedtourist.com
info Medical information on this site is for general reference only and does not constitute medical advice, diagnosis, or treatment recommendations. Actual care decisions rest with the licensed physicians of the hospital.